BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 20027153)

  • 21. Transintestinal transport mechanisms of 5-aminosalicylic acid (in situ rat intestine perfusion, Caco-2 cells) and Biopharmaceutics Classification System.
    Smetanová L; Stětinová V; Kholová D; Kuneš M; Nobilis M; Svoboda Z; Květina J
    Gen Physiol Biophys; 2013 Sep; 32(3):361-9. PubMed ID: 23846255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transport mechanism of swertiamain metabolite across Caco-2 model].
    Tang C; Zhang Y; Zhang T; Tian C; Liu C
    Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(17):2258-60. PubMed ID: 19943498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide by human intestinal Caco-2 cells.
    Zhou S; Feng X; Kestell P; Paxton JW; Baguley BC; Chan E
    Eur J Pharm Sci; 2005 Apr; 24(5):513-24. PubMed ID: 15784341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like Caco-2 cells.
    Jewell C; Cusack S; Cashman KD
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):163-71. PubMed ID: 15664300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport of leuprolide across rat intestine, rabbit intestine and Caco-2 cell monolayer.
    Guo J; Ping Q; Jiang G; Dong J; Qi S; Feng L; Li Z; Li C
    Int J Pharm; 2004 Jul; 278(2):415-22. PubMed ID: 15196645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal permeability of sesquiterpenes in the caco-2 cell monolayer model.
    Wu Q; Zhao B; Yang XW; Xu W; Zhang P; Zou L; Zhang LX
    Planta Med; 2010 Mar; 76(4):319-24. PubMed ID: 19830652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35.
    Yu H; Hu YQ; Ip FC; Zuo Z; Han YF; Ip NY
    Biopharm Drug Dispos; 2011 Apr; 32(3):140-50. PubMed ID: 21271607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):261-70. PubMed ID: 17890067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cocktail approach to standardise Caco-2 permeability experiments.
    Koljonen M; Hakala KS; Ahtola-Sätilä T; Laitinen L; Kostiainen R; Kotiaho T; Kaukonen AM; Hirvonen J
    Eur J Pharm Biopharm; 2006 Nov; 64(3):379-87. PubMed ID: 16914297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of 99mTc-mannitol and 99mTc-PEG in the assessment of paracellular integrity of cell monolayers.
    Shah PJ; Jogani VV; Mishra P; Mishra AK; Bagchi T; Misra AR
    Nucl Med Commun; 2007 Aug; 28(8):653-9. PubMed ID: 17625388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
    Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
    Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models.
    Sun H; Bi H; Huang M; Liu D; Qin Z
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):486-94. PubMed ID: 20936649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transport and metabolism of daidzein in Caco-2 cell model].
    Ge YB; Ma Y; Li WZ
    Zhong Yao Cai; 2009 Oct; 32(10):1563-7. PubMed ID: 20112722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa.
    Miret S; Abrahamse L; de Groene EM
    J Biomol Screen; 2004 Oct; 9(7):598-606. PubMed ID: 15475479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
    Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
    Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport properties of puerarin and effect of Radix Angelicae Dahuricae extract on the transport of puerarin in Caco-2 cell model.
    Liang XL; Zhao LJ; Liao ZG; Zhao GW; Zhang J; Chao YC; Yang M; Yin RL
    J Ethnopharmacol; 2012 Dec; 144(3):677-82. PubMed ID: 23085309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
    Agarwal S; Jain R; Pal D; Mitra AK
    Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.